Lumican is also identified as a marker protein in pancreatic cancer and plays an integral role in the development and progression of both gastrointestinal and non‐gastrointestinal tumours, including liver, gastric, colorectal, lung, breast and prostate cancers [97, 98, 99]. This evidence concerns the gene LUM and prostate carcinoma.